UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Conspecific Negative Density Dependence and Forest Diversity

Science (American Association for the Advancement of Science), 2012-05, Vol.336 (6083), p.904-907

2012

Volltextzugriff (PDF)

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)

Ophthalmology (Rochester, Minn.), 2020-09, Vol.127 (9), p.1201-1210

2020

Volltextzugriff (PDF)

Changes in activity impairment and work productivity after treatment for vitreous hemorrhage due to proliferative diabetic retinopathy: Secondary outcomes from a randomized controlled trial (DRCR Retina Network Protocol AB)

PloS one, 2023-11, Vol.18 (11), p.e0293543-e0293543

2023

Volltextzugriff (PDF)

Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab

Ophthalmology (Rochester, Minn.), 2017-04, Vol.124 (4), p.431-439

2017

Volltextzugriff (PDF)

Panretinal Photocoagulation versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes from a Randomized Clinical Trial

American journal of ophthalmology, 2016-10, Vol.170, p.206-213

2016

Volltextzugriff (PDF)

Diversification of ergot alkaloids and heritable fungal symbionts in morning glories

Communications biology, 2021-12, Vol.4 (1), p.1362-11, Article 1362

2021

Volltextzugriff (PDF)

Phylogenetic and chemotypic diversity of Periglandula species in eight new morning glory hosts (Convolvulaceae)

Mycologia, 2015-07, Vol.107 (4), p.667-678

2015

Volltextzugriff (PDF)

Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial

JAMA ophthalmology, 2018-03, Vol.136 (3), p.257

2018

Volltextzugriff (PDF)

Patient-Reported Outcome Measures in a Clinical Trial of the Port Delivery System With Ranibizumab

JAMA ophthalmology, 2022-08, Vol.140 (8), p.778

2022

Volltextzugriff (PDF)

Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2020-12, Vol.324 (23), p.2383

2020

Volltextzugriff (PDF)

Rationale and Application of the Protocol S Anti–Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy

Ophthalmology (Rochester, Minn.), 2019-01, Vol.126 (1), p.87-95

2019

Volltextzugriff (PDF)

Locomotor analysis identifies early compensatory changes during disease progression and subgroup classification in a mouse model of amyotrophic lateral sclerosis

Neural regeneration research, 2017-10, Vol.12 (10), p.1664-1679

2017

Volltextzugriff (PDF)

Early Response to Anti–Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol T

American journal of ophthalmology, 2018-11, Vol.195, p.93-100

2018

Volltextzugriff (PDF)

Interpreting Multiple Outcomes of Pupillary Light Reflex in Sport-Related Concussion in Adolescents

JAMA ophthalmology, 2020-11, Vol.138 (11), p.1141

2020

Volltextzugriff (PDF)

Bending rules for animal propulsion

Nature communications, 2014-02, Vol.5 (1), p.3293-3293, Article 3293

2014

Volltextzugriff (PDF)

Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes

Ophthalmology (Rochester, Minn.), 2018-11, Vol.125 (11), p.1776-1783

2018

Volltextzugriff (PDF)

Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical Trial

JAMA ophthalmology, 2020-04, Vol.138 (4), p.341

2020

Volltextzugriff (PDF)

Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial

JAMA ophthalmology, 2021-07, Vol.139 (7), p.725

2021

Volltextzugriff (PDF)

Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH

Ophthalmology (Rochester, Minn.), 2021-11, Vol.128 (11), p.1592-1603

2021

Volltextzugriff (PDF)

DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMA

Retina (Philadelphia, Pa.), 2023-04, Vol.43 (4), p.616-623

2023

Volltextzugriff (PDF)

Production of the Alkaloid Swainsonine by a Fungal Endosymbiont of the Ascomycete Order Chaetothyriales in the Host Ipomoea carnea

Journal of agricultural and food chemistry, 2013-04, Vol.61 (16), p.3797-3803

2013

Volltextzugriff (PDF)

ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY: Pooled Analysis of Five DRCR Retina Network Randomized Clinical Trials

Retina (Philadelphia, Pa.), 2020-06, Vol.40 (6), p.1021-1028

2020

Volltextzugriff (PDF)

PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Should Baseline Characteristics Affect Choice of Treatment?

Retina (Philadelphia, Pa.), 2019-09, Vol.39 (9), p.1646-1654

2019

Volltextzugriff (PDF)

Baseline factors associated with myopia progression and axial elongation over 30 months in children 5 to 12 years of age

Optometry and vision science, 2024-10, Vol.101 (10), p.619-626

2024

Volltextzugriff (PDF)

Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration

Translational vision science & technology, 2023-09, Vol.12 (9), p.1-1

2023

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(55)
Dissertationen
(1)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(31)
Ophthalmology
(21)
Humans
(20)
Female
(17)
Male
(17)
Middle Aged
(15)
Intravitreal Injections
(14)
Visual Acuity
(13)
Diabetic Retinopathy
(11)
Diabetic Retinopathy - Drug Therapy
(11)
Aged
(10)
Angiogenesis Inhibitors - Therapeutic Use
(10)
Clinical Trials
(10)
Diabetes
(9)
Vascular Endothelial Growth Factor A - Antagonists & Inhibitors
(9)
Diabetic Retinopathy - Physiopathology
(8)
Ranibizumab - Therapeutic Use
(8)
Diabetes Mellitus
(7)
Retina
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Conspecific Negative Density Dependence and Forest Diversity

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)

Changes in activity impairment and work productivity after treatment for vitreous hemorrhage due to proliferative diabetic retinopathy: Secondary outcomes from a randomized controlled trial (DRCR Retina Network Protocol AB)

Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab

Panretinal Photocoagulation versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes from a Randomized Clinical Trial

Diversification of ergot alkaloids and heritable fungal symbionts in morning glories

Phylogenetic and chemotypic diversity of Periglandula species in eight new morning glory hosts (Convolvulaceae)

Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial

Patient-Reported Outcome Measures in a Clinical Trial of the Port Delivery System With Ranibizumab

Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial

Rationale and Application of the Protocol S Anti–Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy

Locomotor analysis identifies early compensatory changes during disease progression and subgroup classification in a mouse model of amyotrophic lateral sclerosis

Early Response to Anti–Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol T

Interpreting Multiple Outcomes of Pupillary Light Reflex in Sport-Related Concussion in Adolescents

Bending rules for animal propulsion

Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes

Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical Trial

Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial

Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH

DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMA

Production of the Alkaloid Swainsonine by a Fungal Endosymbiont of the Ascomycete Order Chaetothyriales in the Host Ipomoea carnea

ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY: Pooled Analysis of Five DRCR Retina Network Randomized Clinical Trials

PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Should Baseline Characteristics Affect Choice of Treatment?

Baseline factors associated with myopia progression and axial elongation over 30 months in children 5 to 12 years of age

Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration

Aktive Filter

Suchergebnisse filtern